ChiroMed - Company finances
|
EUR
|
2018
From: 2018-09-19
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,220 | 3,600 | 4,930 | 8,377 | 6,190 | 9,680 | 12,479 | 12,760 |
| Profit before tax | 756 | 1,029 | 3,082 | 5,460 | 2,516 | 6,199 | 7,590 | 9,145 |
| Net profit | 756 | 978 | 2,928 | 5,187 | 2,384 | 5,889 | 7,183 | 8,596 |
| Equity | 756 | 1,733 | 4,661 | 9,848 | 3,164 | 4,347 | -1,139 | -111 |
| Liabilities | - | - | - | - | 132 | 596 | 1,980 | 863 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 772 | 1,843 | 4,798 | 10,059 | 3,296 | 4,943 | 841 | 752 |
| Total assets | 772 | 1,843 | 4,798 | 10,059 | 3,296 | 4,943 | 841 | 752 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 857 | 2,193 | 1,717 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +195.1% | +36.9% | +69.9% | -26.1% | +56.4% | +28.9% | +2.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 97.9% | 53.1% | 61.0% | 51.6% | 72.3% | 119.1% | 854.1% | 1143.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 56.4% | 62.8% | 52.7% | 75.3% | 135.5% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 62.0% | 27.2% | 59.4% | 61.9% | 38.5% | 60.8% | 57.6% | 67.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 62.0% | 28.6% | 62.5% | 65.2% | 40.6% | 64.0% | 60.8% | 71.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.0 | 0.1 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ChiroMed - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-12-23 | 2022-12-31 | 1223.97 |
| 2022-07-01 | 2022-07-31 | 50.95 |
ChiroMed - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-22 | 2025-06-23 | 70.28 |
| 2025-06-19 | 2025-06-21 | 70.2 |
| 2024-06-20 | 2025-02-27 | 0.2 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ChiroMed, MB (company code 304919826) is a Small partnership engaged in physiotherapy activities. In the latest financial year, 2025, the company generated €12.8K in revenue, which was 2.2% higher year on year and 31.8% above the 2023 level. Net profit increased to €8.6K in 2025, following €7.2K in 2024 and €5.9K in 2023, showing a steady improvement in earnings over the three-year period. The profit margin strengthened to 67.4% in 2025, compared with 57.6% in 2024 and 60.8% in 2023, reflecting very strong profitability relative to turnover. The balance sheet remains small: total assets were €752 in 2025, down from €841 in 2024 and €4.9K in 2023. Equity was negative at -€111 in 2025, after -€1.1K in 2024, while liabilities stood at €863. Because the equity base is very small and negative, return ratios are heavily distorted and should be interpreted cautiously. Asset turnover is high due to the limited asset base.